Mycoplasma Testing Market Segmentation and Analysis by Recent Trends and Development 2025
The Mycoplasma Testing Market report provides a detailed evaluation of the industry by highlighting information on different aspects which include drivers, restraints, growth opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing. It also provides a detailed analysis of global market size, regional and country-level market size, competitive landscape, impact of domestic market players and value chain optimization. Furthermore, it sheds light on the market contribution, recent developments and successful marketing strategies of leading companies.
Market Insights
The global mycoplasma
testing market was valued at USD 446.9 million in 2016 and is anticipated to
witness a lucrative growth over the forecast period. Rising number of
pharmaceutical and biopharmaceutical companies, increasing R&D investment,
and growing number of drug launches are major attributes that are fuelling the
market.
Increase in the number
of biopharmaceutical and pharmaceutical companies has been seen in the past
years. This growth has been attributed by the need for advanced drugs and
therapies for the treatment of chronic diseases like cancer, diabetes,
cardiovascular diseases and osteoporosis among others. The research work is
supported by the government by funding the pharmaceutical and biotechnology
companies in order to facilitate research based activities for the development
of new drugs. This may foster the growth of mycoplasma testing market.
Request a Sample Copy
of Mycoplasma Testing Market Report @ https://www.millioninsights.com/industry-reports/mycoplasma-testing-market/request-sample
Rising investment in R&D by
dominant players has further resulted in growth of the market. In the year
2016, North America spent 28.4% of its GDP on research and development
according to Global R&D Funding Forecast. This signifies significant rise in
the spending by various companies for the invention of new and enhanced testing
devices and kits. With the growing expenditure by the government in the
healthcare industry and awareness campaigns have led to the growth of the
mycoplasma testing market. Mycoplasma testing is conducted so as to ensure the
product is contamination free during each stage of manufacturing process.
Mycoplasma contamination is a
major cause of concern in research and development activities. Infections
caused by M. orale or M. fermentans are strains that frequently are seen in
humans are a key source of contamination in laboratory settings. These
contaminations in cell cultures cause morphological changes, altered cell
metabolism and chromosomal aberrations causing contamination in the entire cell
line. Contamination may also result in serious complications such as pneumonia,
genital infections and other respiratory disorders is also seen. Thus, to
prevent such contaminations, mycoplasma testing is vital.
Mycoplasma Testing Product Outlook (Revenue, USD Million, 2014 - 2025)
• Instruments
• Kits & Reagents
• PCR Assays
• Nucleic Acid Detection Kits
• Stains
• Elimination Kits
• Standards & Controls
• Others
• Services
Mycoplasma Testing Technology Outlook (Revenue, USD Million, 2014 -
2025)
• PCR
• ELISA
• Direct Assay
• Indirect Assay
• Microbial Culture Techniques
• Enzymatic Methods
Mycoplasma Testing Application Outlook (Revenue, USD Million, 2014 -
2025)
• Cell Line Testing
• Virus Testing
• End of Production Cells Testing
• Others
Mycoplasma Testing End-Use Outlook (Revenue, USD Million, 2014 - 2025)
• Academic Research Institutes
• Cell Banks
• Contract Research Organizations
• Pharmaceutical & Biotechnology
Companies
• Others
Access Mycoplasma
Testing Market Report with TOC @ https://www.millioninsights.com/industry-reports/mycoplasma-testing-market
Top Players Analysis covered in these report
• Charles River Laboratories International
• Merck KGaA
• Thermo Fisher Scientific
• Lonza Group Ltd
• PromoCell
• Bionique Testing Laboratories and many
others
Comments
Post a Comment